May 2014 - Volume 24 - Issue 5 - Contributor Index

Alphabetical Search
Q
U
X
Y
Z
Author:
Alba, Emilio

Identification of genetic variants associated with capecitabine-induced hand–foot syndrome through integration of patient and cell line genomic analyses

Wheeler, Heather E.; González-Neira, Anna; Pita, Guillermo; More

Pharmacogenetics and Genomics. 24(5):231-237, May 2014.

Author:
Alonso, Rosario

Identification of genetic variants associated with capecitabine-induced hand–foot syndrome through integration of patient and cell line genomic analyses

Wheeler, Heather E.; González-Neira, Anna; Pita, Guillermo; More

Pharmacogenetics and Genomics. 24(5):231-237, May 2014.

Author:
Altman, Russ B.
Author:
Caliz, Rafael

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

Author:
Cheng, Cheng

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

Identification of genetic variants associated with capecitabine-induced hand–foot syndrome through integration of patient and cell line genomic analyses

Wheeler, Heather E.; González-Neira, Anna; Pita, Guillermo; More

Pharmacogenetics and Genomics. 24(5):231-237, May 2014.

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

Identification of genetic variants associated with capecitabine-induced hand–foot syndrome through integration of patient and cell line genomic analyses

Wheeler, Heather E.; González-Neira, Anna; Pita, Guillermo; More

Pharmacogenetics and Genomics. 24(5):231-237, May 2014.

Author:
Endo, Takeo

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma

Konno, Satoshi; Hizawa, Nobuyuki; Makita, Hironi; More

Pharmacogenetics and Genomics. 24(5):246-255, May 2014.

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

Identification of genetic variants associated with capecitabine-induced hand–foot syndrome through integration of patient and cell line genomic analyses

Wheeler, Heather E.; González-Neira, Anna; Pita, Guillermo; More

Pharmacogenetics and Genomics. 24(5):231-237, May 2014.

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma

Konno, Satoshi; Hizawa, Nobuyuki; Makita, Hironi; More

Pharmacogenetics and Genomics. 24(5):246-255, May 2014.

Author:
Iijima, Hiroaki

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma

Konno, Satoshi; Hizawa, Nobuyuki; Makita, Hironi; More

Pharmacogenetics and Genomics. 24(5):246-255, May 2014.

Author:
Ito, Yoichi M.

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma

Konno, Satoshi; Hizawa, Nobuyuki; Makita, Hironi; More

Pharmacogenetics and Genomics. 24(5):246-255, May 2014.

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma

Konno, Satoshi; Hizawa, Nobuyuki; Makita, Hironi; More

Pharmacogenetics and Genomics. 24(5):246-255, May 2014.

Author:
Janke, Laura J.
Author:
Joven, Beatriz

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma

Konno, Satoshi; Hizawa, Nobuyuki; Makita, Hironi; More

Pharmacogenetics and Genomics. 24(5):246-255, May 2014.

Author:
Klein, Teri E.
Author:
Kokubu, Fumio

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma

Konno, Satoshi; Hizawa, Nobuyuki; Makita, Hironi; More

Pharmacogenetics and Genomics. 24(5):246-255, May 2014.

Author:
Konno, Satoshi

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma

Konno, Satoshi; Hizawa, Nobuyuki; Makita, Hironi; More

Pharmacogenetics and Genomics. 24(5):246-255, May 2014.

Identification of genetic variants associated with capecitabine-induced hand–foot syndrome through integration of patient and cell line genomic analyses

Wheeler, Heather E.; González-Neira, Anna; Pita, Guillermo; More

Pharmacogenetics and Genomics. 24(5):231-237, May 2014.

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

Author:
Makita, Hironi

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma

Konno, Satoshi; Hizawa, Nobuyuki; Makita, Hironi; More

Pharmacogenetics and Genomics. 24(5):246-255, May 2014.

Author:
Marquet, Pierre
Author:
Martín, Miguel

Identification of genetic variants associated with capecitabine-induced hand–foot syndrome through integration of patient and cell line genomic analyses

Wheeler, Heather E.; González-Neira, Anna; Pita, Guillermo; More

Pharmacogenetics and Genomics. 24(5):231-237, May 2014.

Author:
Molden, Espen
Author:
Montes, Ariana

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma

Konno, Satoshi; Hizawa, Nobuyuki; Makita, Hironi; More

Pharmacogenetics and Genomics. 24(5):246-255, May 2014.

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma

Konno, Satoshi; Hizawa, Nobuyuki; Makita, Hironi; More

Pharmacogenetics and Genomics. 24(5):246-255, May 2014.

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

Author:
Picard, Nicolas
Author:
Pita, Guillermo

Identification of genetic variants associated with capecitabine-induced hand–foot syndrome through integration of patient and cell line genomic analyses

Wheeler, Heather E.; González-Neira, Anna; Pita, Guillermo; More

Pharmacogenetics and Genomics. 24(5):231-237, May 2014.

Author:
Saito, Takefumi

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma

Konno, Satoshi; Hizawa, Nobuyuki; Makita, Hironi; More

Pharmacogenetics and Genomics. 24(5):246-255, May 2014.

Author:
Sakamoto, Tohru

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma

Konno, Satoshi; Hizawa, Nobuyuki; Makita, Hironi; More

Pharmacogenetics and Genomics. 24(5):246-255, May 2014.

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma

Konno, Satoshi; Hizawa, Nobuyuki; Makita, Hironi; More

Pharmacogenetics and Genomics. 24(5):246-255, May 2014.

Author:
Touchard, Guy

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

Montes, Ariana; Perez-Pampin, Eva; Narváez, Javier; More

Pharmacogenetics and Genomics. 24(5):238-245, May 2014.

Identification of genetic variants associated with capecitabine-induced hand–foot syndrome through integration of patient and cell line genomic analyses

Wheeler, Heather E.; González-Neira, Anna; Pita, Guillermo; More

Pharmacogenetics and Genomics. 24(5):231-237, May 2014.

Show: